Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ImmGenics and Genzyme enter collaboration agreement to use SLAM technology

Oct. 4, 1999

Molecumetics and P&U enter collaboration for caspase research

Sep. 30, 1999

Medarex enters HuMAb-Mouse antibody agreement with Amgen

Sep. 28, 1999

Fournier synthesizes novel potent B2 agonists resistant to enzymatic degradation

Sep. 24, 1999

Bristol-Myers Squibb enters target validation collaboration with Exelixis

Sep. 23, 1999

M.D. Anderson Cancer Center and Cryogenic Solutions enter antisense collaboration

Sep. 22, 1999

Japanese coalition formed for development of new drugs

Sep. 21, 1999

Unique new selective FP receptor antagonist characterized by Alcon

Sep. 20, 1999

Oxford GlycoSciences and Cellular Genomics form proteomics collaboration

Sep. 20, 1999

Myriad Genetics establishes strategic alliance with Galileo Genomics

Sep. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...